Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 6Pain 5Breast Neoplasms 5Pain, Postoperative 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Postoperative Nausea and Vomiting 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Chronic Pain 1Cancer Pain 1

Interventions

Morphine 11Oxycodone 8Fentanyl 6nabiximols 5Methadone 4Hydromorphone 4Acetaminophen 3Transcutaneous Electric Nerve Stimulation 2Tapentadol 2Naloxone 2Lidocaine 2Buprenorphine 2Acupuncture Therapy 2tanezumab 1resiniferatoxin 1oxycodone naloxone combination 1fulranumab 1cannabichromene 1alvimopan 1Water 1Ultracet 1Transcranial Direct Current Stimulation 1Tramadol 1Therapeutic Touch 1Telemedicine 1Tablets 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cancer Pain × Analgesics, Opioid × Clear all
NCT01541124 2018-02-08

Morphine as First Drug for Cancer Pain

Federal University of São Paulo

Phase NA Completed
60 enrolled

Cancer Pain, Agnosia, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡